✦ LIBER ✦

413 POSTER A phase I dose escalation study of oral SB939 when administered thrice weekly (every other day) for 3 weeks in a 4-week cycle in patients with advanced solid malignancies

✍ Scribed by W.P. Yong; B.C. Goh; K. Ethirajulu; P. Yeo; O. Otheris; S.M. Chao; R. Soo; W.L. Yeo; E. Seah; J. Zhu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of vinflun

✍ Calvo, E.; Vermorken, J. B.; Hiret, S.; Rodon, J.; Cortes, J.; Senellart, H.; de 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 242 KB

496 A phase I dose-escalation study of B

✍ M. Scheulen; K. Mross; H. Richly; B. Nokay; A. Frost; D. Scharr; K.H. Lee; O. Sa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB